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Recently, there has been considerable interest in the isolation and long-term culture 
of monospeeific cytolytic T  lymphoeytes. If such cells could be isolated and grown in 
large  numbers,  studies  could  be  conducted  on  the  mechanism  of T-cell-mediated 
cytolysis,  the  identification  and  molecular  characterization  of the  T-cell  antigen 
receptor,  and the identification  of cytolytic T-ceU differentiation  markers.  We previ- 
ously  reported  the  successful  maintenance  of murine  cytolytic T  cells  in  sustained 
exponential  proliferative  culture  with  the  aid  of T-cell  growth  factor  (TCGF)  (1). 
One such cytotoxic T-lymphocyte line (CTLL-2) has remained in culture for 2 yr and 
has retained both its cytolytic specificity and capacity. We report here the successful 
creation of cloned monospecific cytolytic T-cell lines from CTLL-2. 
Materials  and Methods 
Derivation of CTLL-2.  CTLL-2 was initiated  from spleen cells of a C57B1/6 mouse (H-2  b) 
which had been inoculated with allogeneic Friend leukemia virus (FLV)-induced erythroleu- 
kemia cells, F4-5 (H-2a). Before initiation of TCGF-dependent culture, a secondary and tertiary 
in vitro mixed tumor-lymphocyte culture was performed using mitomycin-C inactivated F4-5 
stimulator cells (2). Effector T  cells harvested from these cultures were found to mediate both 
allogeneic and syngeneic tumor-specific cytolysis (2). 
Long-Term Culture of CTLL-2.  For continuous growth, CTLL-2 cells were seeded at  1 ×  10  ~ 
ceils/ml in complete Click's medium (Ahick Associates,  Hudson, Wis.):  TCGF,  1:1 (vol/vol). 
Click's medium was supplemented with 2% fetal calf serum (FCS), 100 #g/ml fresh L-glutamine, 
50 U/ml penicillin, 50/~g/ml gentamiein,  16 mM/ml NaHCO3, and 25 mM/ml Hepes Buffer 
(Calbiochem, San Diego, Calif.).  After saturation density was reached (5  X  105 cells/ml)  the 
cultures were reseeded to  1  ×  104 cells/ml. CTLL-2 has been maintained  in culture in this 
fashion for more than 2 yr. During this period the cells have remained Thy-1 antigen positive 
and surface immunoglobulin negative. 
The production and assay of TCGF were according to previously described methods  (3). 
TCGF  used  for  studies  described  here  was  derived  from  medium  conditioned  by  48  h 
concanavalin A ([5 lag/ml] [Miles-Yeda Laboratories, Rehovoth, Israel])  stimulation of CD rat 
(Sprague-Dawley, Charles River Breeding Laboratories, Wilmington, Mass.)  spleen cells. 
Creation of Cloned CTLL.  CTLL-2 cells,  14 mo after initiation of culture, were adjusted to 
1.2, 1.0, 0.6, and 0.5 cells/mi in complete Click's medium: TCGF, 1:1 (vol/vol), and 250 #1 was 
delivered  to  individual  wells  of flat-bottomed  microtiter  plates  (3596,  Costar,  Cambridge, 
Mass.).  After 10-14 d at 37°C in a humidified atmosphere of 5% CO2 in air, cells were seeded 
into 6-well cluster plates (3506, Costar). After reaching a saturation density of 5 ×  10  n eells/ml, 
cloned cells were seeded into culture flasks (3013, BioQuest, BBL Falcon Products, Cockeysville, 
Md.) and maintained in a state of TCGF-dependent exponential proliferation. 
Lymphocyte-Mediated Cytolysis (LMC) Assay.  FBL-3(Hn) (H-2b), P815 (H-2  d) and F4-5 (H-2  d) 
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Fio.  1.  eytotoxicity of GTLL-2 against the allogeneic tumor, F4-5 (O), the syngeneic tumor, FBL- 
3(Hn) (R), normal syngeneic thymus cells (&), and syngeneic Con A-induced blast cells (V). 
tumor cell  lines  (2) maintained  in RPMI-1640 medium (Grand Island Biological  Co., Grand 
Island, N. Y.) supplemented with 10% heat-inactivated FCS, 300/xg/ml e-glutamine, 50 U/ml 
penicillin-G, 50 #g/ml gentamicin, and 2.5  ×  10  -5 M  2-mercaptoethanol, were used as targets 
in 4 h 51Cr-release assays as previously described  (2). In LMC assays  performed using cloned 
effector populations,  P815  was chosen as  the  allogeneic  target  rather  than  F4-5  because  it 
allowed the detection of alloantigen-directed cytolysis in the absence of antigens associated with 
FLV-induced transformation. 
Results 
The  lysis  of allogeneic  FLV-induced  F4-5  leukemia  cells  and  syngeneic  FLV- 
induced  FBL-3(Hn)  leukemia  cells,  mediated  by  CTLL-2  after  17  wk  of TCGF- 
dependent culture is shown in Fig.  1. Although both tumor targets were lysed, normal 
syngeneic targets were uneffected. Because cytolysis of both allogeneic and syngeneic 
tumor cells occurred, we speculated that CTLL-2 might be composed of at least  two 
different  effector cell subpopulations;  one with  alloantigen  specificity, and one with 
tumor-antigen  specificity.  To  investigate  this  possibility,  CTLL-2  was  cloned  by 
limiting dilution as displayed in Table I. 
Cells were seeded in microtiter plates at concentrations ranging from 0.30 to 0.13 
cells per cloning well. At these cell concentrations, the Poisson calculated probability 
of any single cloning well  populated  by only one cell  (P  (K  =  1))  was 0.22  to 0.11. 
The probability of any cloning well being copopulated by more than one cell  (P (K 
>  1))  ranged  from 0.04  to less  than  0.01.  The total  percentage  of calculated  fertile 
wells including those expected to be monoclonal and those expected to be polyclonal 
was  thus  0.26  to  0.12.  By  comparing  these  data  with  the  number  of fertile  wells 
observed,  plating  efficiency was  found  to  range  from  67  to  100%.  This  numerical 
analysis suggests that all clones produced, originated from single cells  (P <  0.05). 
To discern whether the clones displayed monospecific cytotoxic activity, P815 and 
FBL-3(Hn)  tumor cell lines were employed as targets in LMC assays. Each of the 24 BAKER ET AL  BRIEF DEFINITIVE REPORT 
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Clone No. 
No.  Poisson probability  No. of wells: 
cells/well 
plated  P (K --- 1)*  P (K >  1)*  Plated  Expected  Grown 
Plating effi- 
ciency 
% 
1, 2, 3, 5, 6, 7  0.30  0.22  0.04  24  6  6  100 
16, 17, 18, 19, 20  0.25  0.20  0.02  46  10  9  90 
21, 22, 23, 24 
4, 8  0.15  0.13  0.01  24  3  2  67 
9, 10, 11, 12, 13  0.13  0.11  0.01  84  10  7  70 
14, 15 
* Poisson calculated probability  of one cell occupying any one well. 
Poisson calculated probability of more than one cell occupying any one well. 
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FIG. 2.  Representative cytotoxicity of CTLL-2 clones against the allogeneic tumor P815 (9)) and 
the syngeneic tumor FBL-3(Hn) (A); A, clone 3; B, clone 15; C, clone 24; and D, clone 20. 
clones  isolated  displayed one  of four  patterns  of cytotoxic reactivity, examples  of 
which are graphed in Fig. 2.  10 clones (42%) effectively lysed the allogeneic target cell 
(P815)  as represented by clone 3  (Fig. 2 A). Four clones (17%)  preferentially lysed the 
syngeneic tumor  target  cell as represented  by clone  15  (Fig.  2B).  Six clones  (25%) 
lysed both allogeneic and syngeneic tumor cell targets with equal efficiency (Fig. 2 C, 
clone 24) and four clones (17%) displayed no cytotoxic reactivity whatsoever (Fig. 2 D, 
clone 20). The data displayed in Fig. 2 therefore confirmed our hypothesis that CTLL- 
2  contained at  least  two distinct antigen-specific cytotoxic effector cell populations. 276 
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FIG.  3.  The stability ofclonal cytolytic specificity.  Upper panels depict lytic pattern of FBL-3(Hn) 
(&) and P815  (0) mediated by clone 15 after: A, 4 wk;  B, 8 wk;  and C,  13 wk of culture. Lower 
panels depict lyric pattern of FBL-3(Hn) (A) and P815 (U]) mediated by clone 20 after: D, 4 wk; E, 
7 wk; and F, 8 wk of cuhure. 
To determine whether the  pattern of lysis mediated  by cloned CTLL remained 
stable, two clones were selected and tested at successive intervals during several weeks 
of culture.  As  shown  in  Fig.  3A,  B,  and  C,  clone  15  consistently  mediated  the 
preferential lysis of the syngeneic tumor target cell FBL-3(Hn). Similarly, clone 20 
which displayed no cytotoxic activity initially, remained nonreactive during 8 wk of 
culture, even when tested at effector to target cell ratios as high as  1,000:1  (Fig. 3 D, 
E, and F). 
As  a  final demonstration that  cloned CTLL-2 cells were established  from single 
cells, clone  15 was selected and  five subclones were created by seeding the cells at 
limiting dilutions (0.13/cells per well) in microtiter plates. If cloned CTLL were truly 
derived from a single cell, one would expect to find identical patterns of lysis in all 
subclones cultured from a single CTLL clone. As shown in Fig. 4, the five subclones 
of clone 15 displayed lysis patterns identical to the parent CTLL clone. 
Discussion 
This experimentation represents  the  first  report  of the  isolation  of monospecific 
cytolytic T  cells and the maintenance of such cells in proliferative culture. Fathman 
and  Hengartner have successfully cloned alloreactive murine T  cells;  however, the 
clones lost the capacity to mediate specific cytolysis when maintained by repetitive 
alloantigen stimulation (4). Nabholz et al. attempted to clone alloreactive cytolytic T 
cells in soft agar, however monospecific cytolytic function was not demonstrated (5). 
By  using  the  methods  described  herein,  it  should  now  be  possible  to  detail  the 
functional and phenotypic characteristics of differentiated antigen-specific cytolytic 
T  cells.  Furthermore, our recent findings regarding the long-term culture of human 
cytolytic T-cell lines  (6)  compounded  with  these  results,  provide evidence that  it A. 
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Flo.  4.  Cytotoxicity of clone  15 and subclones against FBL-3(Hn)  (&)  and P815  (0)  6 wk after 
isolation of the subelones; A, clone  15;  B, subclone  15-1;  C, subclone  15-2;  D, subelone  15-3;  E, 
subclone 15-4;  and F, subclone 15-5. 
should be possible to create monospecific cytolytic human T-cell lines. 
It is of interest that greater than 80% of the clones derived from CTLL-2 expressed 
cytolytic function. One would not necessarily have predicted such a  high frequency 
of cytolytic clones in light of recently reported evidence that precursors of cytotoxic 
cells comprise  less  than  10%  of splenic  T  cells  (7).  It  is  possible  that  the  tertiary 
allogeneic  MTLC  used  to  derive  CTLL-2  effector cells  in  some  way  selected  for 
cytotoxic cells. Alternatively, TCGF may preferentially act on cytolytic cells rather 
than helper or suppressor T  cells. In other experimentation we have found that only 
mitogen or antigen-activated T  cells absorb TCGF activity  1 suggesting that activated 
T  cells  express a  TCGF receptor. Our  cloning data  would  suggest  therefore, that 
cytotoxic T  cells may express receptors with a  higher TCGF affinity than helper or 
suppressor T  cells. 
Although  the exact  biochemical nature of TCGF remains  to be elucidated, our 
previous studies (3, 8) indicate that TCGF is the second signal in the T-cell immune 
response  and  that  it  functions  to  mediate  the  proliferative expansion  of antigen- 
activated T-cell clones. The observation that it is possible to select and clone cytolytic 
T  cells in vitro using TCGF, coupled with the ability to maintain such clones in an 
apparent  indefinite  TCGF-dependent  proliferative  state,  should  greatly  facilitate 
future studies of differentiated cytolytic T  cells. 
Summary 
Monospecific cloned cytolytic T-lymphocyte lines have been created utilizing T- 
i K. A. Smith et al. Manuscript in preparation. 278  BAKER ET AL.  BRIEF  DEFINITIVE REPORT 
cell  growth  factor.  The  clones  were  found  to  retain  their  cytolytic specificity  after 
prolonged culture  and  monospeeific function was demonstrated  by subcloning pro- 
cedures.  Thus,  detailed  studies  of the  phenotypic  and  functional  characteristics  of 
monospecific, homogeneous, cytolytic T  lymphocytes will now be possible. 
We thank Ms. Rachel Stocking for excellent technical assistance and Ms. Linda Waidlich for 
her administrative expertise in the preparation of the manuscript. 
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